Viral Hepatitis

Atlas of Sexually Transmitted Diseases and AIDS, Fourth Edition

Volumn , Issue , 2010, Pages 203-229

  Hu, D J ^a   Bower, W A ^b   Ward, J W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960804956     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-4060-3.00012-0     Document Type: Chapter

References (290)

1. D Daniels, S Grytdal and A Wasley (2009) Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill Summ 58 1-27.
2. AE Fiore, A Wasley and BP Bell (2006) Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(RR-7), 1-23.
3. YF Liaw and CM Chu (2009) Hepatitis B virus infection. Lancet 373 582-592.
4. D Lavanchy (2009) The global burden of hepatitis C. Liver Int 29(Suppl. 1), 74-81.
5. LB Polish, M Gallagher, HA Fields and SC Hadler (Jul 1993) Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 6 211-229.
6. RH Purcell and SU Emerson (2008) Hepatitis E: an emerging awareness of an old disease. J Hepatol 48 494-503.
7. OV Nainan, G Xia, G Vaughan and HS Margolis (2006) Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 19 63-79.
8. JI Cohen, S Feinstone and RH Purcell (1989) Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis 160 887-890.
9. WA Bower, OV Nainan, XH Han and HS Margolis (2000) Duration of viremia in hepatitis A virus infection. Journal of Infectious Diseases 182 12-17.
10. KH Jacobsen and JS Koopman (2004) Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 132 1005-1022.
11. CN Shapiro and HS Margolis (1993) Worldwide epidemiology of hepatitis A virus infection. J Hepatol 18(Suppl. 2), S11-S14.
12. Hepatitis A among homosexual men–United States, Canada, and Australia. MMWR Morb Mortal Wkly Rep 41(155), 161-164. Anonymous
13. L Corey and KK Holmes (1980) Sexual transmission of hepatitis A in homosexual men: incidence and mechanism. N Engl J Med 302 435-438.
14. MH Katz, L Hsu, E Wong, S Liska, L Anderson and RS Janssen (1997) Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. J Infect Dis 175 1225-1229.
15. ML Stokes, MJ Ferson and LC Young (1997) Outbreak of hepatitis A among homosexual men in Sydney. Am J Public Health 87 2039-2041.
16. C Wheeler, TM Vogt, GL Armstrong, et al. (2005) An outbreak of hepatitis A associated with green onions. N Engl J Med 353 890-897.
17. AE Fiore (2004) Hepatitis A transmitted by food. Clin Infect Dis 38 705-715.
18. KJ Henning, E Bell, J Braun and ND Barker (1995) A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am J Med 99 132-136.
19. RA Coutinho, P Albrecht-van Lent, N Lelie, N Nagelkerke, H Kuipers and T Rijsdijk (1983) Prevalence and incidence of hepatitis A among male homosexuals. Br Med J (Clin Res Ed) 287 1743-1745.
20. P Kryger, NS Pedersen, L Mathiesen and JO Nielsen (1982) Increased risk of infection with hepatitis A and B viruses in men with a history of syphilis: relation to sexual contacts. J Infect Dis 145 23-26.
21. ES McFarlane, JA Embil, FR Manuel and HJ Thiebaux (1981) Antibodies to hepatitis A antigen in relation to the number of lifetime sexual partners in patients attending an STD clinic. Br J Vener Dis 57 58-61.
22. Hepatitis A vaccination of men who have sex with men–Atlanta, Georgia, 1996–1997. MMWR Morb Mortal Wkly Rep 47 708-711. Anonymous
23. EE Mast, CM Weinbaum, AE Fiore, et al. (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 55(RR-16), 1-33. quiz CE31–34
24. R Corona, T Stroffolini, A Giglio, et al. (1999) Lack of evidence for increased risk of hepatitis A infection in homosexual men. Epidemiol Infect 123 89-93.
25. A Bell, F Ncube, A Hansell, et al. (2001) An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health 4 163-170.
26. WM Lednar, SM Lemon, JW Kirkpatrick, RR Redfield, ML Fields and PW Kelley (1985) Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 122 226-233.
27. TM Vogt, ME Wise, BP Bell and L Finelli (2008) Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis 197 1282-1288.
28. A Leentvaar-Kuijpers, JL Kool, PJ Veugelers, RA Coutinho and GJ van Griensven (1995) An outbreak of hepatitis A among homosexual men in Amsterdam, 1991–1993. Int J Epidemiol 24 218-222.
29. YF Liaw, CY Yang, CM Chu and MJ Huang (1986) Appearance and persistence of hepatitis A IgM antibody in acute clinical hepatitis A observed in an outbreak. Infection 14 156-158.
30. JT Stapleton (1995) Host immune response to hepatitis A virus. J Infect Dis 171(Suppl. 1), S9-S14.
31. J O'Grady (1992) Management of acute and fulminant hepatitis A. Vaccine 10(Suppl. 1), S21-S23.
32. KA Workowski and SM Berman (2006) Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 55(RR-11), 1-94.
33. SM Cotter, S Sansom, T Long, et al. (2003) Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis 187 1235-1240.
34. JC Victor, TY Surdina, SZ Suleimenova, MO Favorov, BP Bell and AS Monto (2006) Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Am J Epidemiol 163 204-210.
35. EJ Cohn, JL Oncley, LE Strong, WL Hughes and SH Armstrong (1944) Chemical, clinical, and immunological studies on the products of human plasma fractionation. I. The characterization of the protein fractions of human plasma. J Clin Invest 23 417-432.
36. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR Morb Mortal Wkly Rep 35 231-233. Anonymous
37. JS Bresee, EE Mast, PJ Coleman, et al. (1996) Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 276 1563-1567.
38. Y Ashur, R Adler, M Rowe and D Shouval (1999) Comparison of immunogenicity of two hepatitis A vaccines–VAQTA and HAVRIX–in young adults. Vaccine 17 2290-2296.
39. XQ Chen, M Bulbul, GC de Gast, AM van Loon, DR Nalin and J van Hattum (1997) Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults. J Hepatol 26 260-264.
40. R Clemens, A Safary, A Hepburn, C Roche, WJ Stanbury and FE Andre (1995) Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 171(Suppl. 1), S44-S49.
41. BJ McMahon, J Williams, L Bulkow, et al. (1995) Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis 171 676-679.
42. DR Nalin, BJ Kuter, L Brown, et al. (1993) Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J Hepatol 18(Suppl. 2), S51-S55.
43. LL Hammitt, L Bulkow, TW Hennessy, et al. (2008) Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 198 1776-1782.
44. BL Innis, R Snitbhan, P Kunasol, et al. (1994) Protection against hepatitis A by an inactivated vaccine. JAMA 271 1328-1334.
45. A Werzberger, B Mensch, B Kuter, et al. (1992) A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 327 453-457.
46. S Thoelen, P Van Damme, A Leentvaar-Kuypers, et al. (1999) The first combined vaccine against hepatitis A and B: an overview. Vaccine 17 1657-1662.
47. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48(RR-12), 1-37. Anonymous
48. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45(RR-15), 1-30. Anonymous
49. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees. MMWR Morb Mortal Wkly Rep 58 1006-1007.
50. C Diamond, H Thiede, T Perdue, et al. (2003) Viral hepatitis among young men who have sex with men: prevalence of infection, risk behaviors, and vaccination. Sex Transm Dis 30 425-432.
51. M Gerlich, P Gschwend, A Uchtenhagen, A Kramer and J Rehm (2006) Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. Eur J Epidemiol 21 545-549.
52. JC Victor, AS Monto, TY Surdina, et al. (2007) Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357 1685-1694.
53. Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 56 1080-1084.
54. J Stokes and JR Neefe (1945) The prevention and attenuation of infectious hepatitis by gamma globulin: Preliminary note. JAMA 125 144-145.
55. HH Handsfield (2005) Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases. Am J Med 118(Suppl. 10A), 69S-74S.
56. MJ Mimiaga, SL Reisner, R Vanderwarker, et al. (2008) Polysubstance use and HIV/STD risk behavior among Massachusetts men who have sex with men accessing Department of Public Health mobile van services: implications for intervention development. AIDS Patient Care STDS 22 745-751.
57. TM Block, H Guo and JT Guo (2007) Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 11 685-706. vii
58. FB Hollinger (2007) Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 14(Suppl. 1), 11-15.
59. MJ Koziel (1996) Immunology of viral hepatitis. Am J Med 100 98-109.
60. A Valsamakis (2007) Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev 20 426-439. table of contents
61. EE Mast, HS Margolis, AE Fiore, et al. (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 54(RR-16), 1-31.
62. DP Francis, MS Favero and JE Maynard (1981) Transmission of hepatitis B virus. Semin Liver Dis 1 27-32.
63. LG Davis, DJ Weber and SM Lemon (1989) Horizontal transmission of hepatitis B virus. Lancet 1 889-893.
64. W Szmuness, EJ Harley and AM Prince (1975) Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci 270 293-304.
65. DJ Hu, MA Kane and DL Heymann (1991) Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health Organization. Bull World Health Organ 69 623-630.
66. ND Thompson, JF Perz, AC Moorman and SD Holmberg (2009) Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med 150 33-39.
67. D Lavanchy (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34(Suppl. 1), S1-S3.
68. JF Perz, GL Armstrong, LA Farrington, YJ Hutin and BP Bell (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45 529-538.
69. ST Goldstein, F Zhou, SC Hadler, BP Bell, EE Mast and HS Margolis (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 1329-1339.
70. WR Kim (2009) Epidemiology of hepatitis B in the United States. Hepatology 49(Suppl. 5), S28-S34.
71. TA Lee, DL Veenstra, UH Iloeje and SD Sullivan (2004) Cost of chronic hepatitis B infection in the United States. J Clin Gastroenterol 38(Suppl. 3), S144-S147.
72. GM McQuillan, PJ Coleman, D Kruszon-Moran, LA Moyer, SB Lambert and HS Margolis (1999) Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 89 14-18.
73. MJ Alter and HS Margolis (1990) The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 74 1529-1541.
74. KW Fulford, DS Dane, RD Catterall, R Woof and JV Denning (1973) Australia antigen and antibody among patients attending a clinic for sexually transmitted diseases. Lancet 1 1470-1473.
75. DJ Jeffries, WH James, FJ Jefferiss, KG MacLeod and RR Willcox (1973) Australia (hepatitis-associated) antigen in patients attending a venereal disease clinic. Br Med J 2 455-456.
76. DE Dietzman, JP Harnisch, CG Ray, ER Alexander and KK Holmes (1977) Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men. JAMA 238 2625-2626.
77. L Yuan and G Robinson (1994) Hepatitis B vaccination and screening for markers at a sexually transmitted disease clinic for men. Can J Public Health 85 338-341.
78. RJ Gilson, A de Ruiter, J Waite, et al. (1998) Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Infect 74 110-115.
79. DA MacKellar, LA Valleroy, GM Secura, et al. (2001) Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 91 965-971.
80. RA Gunn, PJ Murray, ML Ackers, WG Hardison and HS Margolis (2001) Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis 28 166-170.
81. DL Thomas, RO Cannon, CN Shapiro, EW Hook 3rd, MJ Alter and TC Quinn (1994) Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 169 990-995.
82. RS Koff, MM Slavin, JD Connelly and DR Rosen (1977) Contagiousness of acute hepatitis B. Secondary attack rates in household contacts. Gastroenterology 72 297-300.
83. CJ Peters, RH Purcell, JJ Lander and KM Johnson (1976) Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts. J Infect Dis 134 218-223.
84. AG Redeker, JW Mosley, DJ Gocke, AP McKee and W Pollack (1975) Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 293 1055-1059.
85. J Heathcote, P Gateau and S Sherlock (1974) Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. Lancet 2 370-371.
86. GR Irwin, AM Allen, WH Bancroft, JJ Karwacki, RH Pinkerton and PK Russell (1974) Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers. JAMA 227 1042-1043.
87. G Papaevangelou, D Trichopoulos, T Kremastinou and G Papoutsakis (1974) Prevalence of hepatitis B antigen and antibody in prostitutes. Br Med J 2 256-258.
88. E Adam, FB Hollinger, JL Melnick, A Duenas and WE Rawls (1974) Type B hepatitis antigen and antibody among prostitutes and nuns: a study of possible venereal transmission. J Infect Dis 129 317-321.
89. MJ Alter, J Ahtone, I Weisfuse, K Starko, TD Vacalis and JE Maynard (1986) Hepatitis B virus transmission between heterosexuals. JAMA 256 1307-1310.
90. GM McQuillan, TR Townsend, HA Fields, M Carroll, M Leahy and BF Polk (1989) Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 87(3A), 5S-10S.
91. S Krugman, LR Overby, IK Mushahwar, CM Ling, GG Frosner and F Deinhardt (1979) Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 300 101-106.
92. JH Hoofnagle and AM Di Bisceglie (1991) Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 11 73-83.
93. BJ McMahon, WL Alward, DB Hall, et al. (1985) Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 599-603.
94. SC Pappas (Mar 1995) Fulminant viral hepatitis. Gastroenterol Clin North Am 24(1), 161-173.
95. WJ Edmunds, GF Medley, DJ Nokes, AJ Hall and HC Whittle (1993) The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 253 197-201.
96. FV Chisari and C Ferrari (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13 29-60.
97. AS Lok and BJ McMahon (2009) Chronic hepatitis B: update 2009. Hepatology 50 661-662.
98. D Ganem and AM Prince (2004) Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 350 1118-1129.
99. YF Liaw (2009) Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 29(Suppl. 1), 100-107.
100. YF Liaw, N Leung, JH Kao, et al. (2008) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2 263-283.
101. DJ Gocke, K Hsu, C Morgan, S Bombardieri, M Lockshin and CL Christian (1970) Association between polyarteritis and Australia antigen. Lancet 2 1149-1153.
102. DJ Gocke, K Hsu, C Morgan, S Bombardieri, M Lockshin and CL Christian (1971) Vasculitis in association with Australia antigen. J Exp Med 134(3 Pt 2), 330s-336s.
103. C Trepo and L Guillevin (2001) Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 16 269-274.
104. R Biswas, E Tabor, CC Hsia, et al. (2003) Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43 788-798.
105. MC Kuhns and MP Busch (2006) New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther 10 77-91.
106. B Kloster, R Kramer, T Eastlund, B Grossman and B Zarvan (1995) Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 35 475-477.
107. ER Lunn, BJ Hoggarth and WJ Cook (2000) Prolonged hepatitis B surface antigenemia after vaccination. Pediatrics 105 E81.
108. SC Hadler, BL Murphy, CA Schable, WL Heyward, DP Francis and MA Kane (1984) Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol 19 521-525.
109. AS Lok, CL Lai and PC Wu (1988) Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 8 766-770.
110. EB Keeffe, DT Dieterich, SH Han, et al. (2008) A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6 1315-1341. quiz 1286
111. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep 38(Suppl. 6), 1-37.
112. CM Weinbaum, I Williams, EE Mast, et al. (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 57(RR-8), 1-20.
113. EB Keeffe, DT Dieterich, JM Pawlotsky and Y Benhamou (2008) Chronic hepatitis B: preventing, detecting, and managing viral resistance. Clin Gastroenterol Hepatol 6 268-274.
114. European Association For The Study Of The L (2009) EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50 227-242.
115. CJ Chen, HI Yang and UH Iloeje (2009) Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 49(Suppl. 5), S72-S84.
116. UH Iloeje, HI Yang, CL Jen, et al. (2007) Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 5 921-931.
117. UH Iloeje, HI Yang, J Su, CL Jen, SL You and CJ Chen (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 678-686.
118. CL Lai, RN Chien, NW Leung, et al. (1998) A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 339 61-68.
119. CL Lai, E Gane, YF Liaw, et al. (2007) Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med 357 2576-2588.
120. AM Di Bisceglie, TL Fong, MW Fried, et al. (1993) A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Am J Gastroenterol 88 1887-1892.
121. DK Wong, AM Cheung, K O'Rourke, CD Naylor, AS Detsky and J Heathcote (1993) Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119 312-323.
122. C Niederau, T Heintges, S Lange, et al. (1996) Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 334 1422-1427.
123. CJ Chu and SD Lee (2008) Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 23 512-520.
124. M Sherman (2009) Strategies for managing coinfection with hepatitis B virus and HIV. Cleve Clin J Med 76(Suppl. 3), S30-S33.
125. CL Thio (2009) Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49(Suppl. 5), S138-S145.
126. K Ikeda, S Saitoh, I Koida, et al. (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18 47-53.
127. JS Wu, LY Hwang, KJ Goodman and RP Beasley (1999) Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 179 1319-1325.
128. M Resti, C Azzari, F Mannelli, ME Rossi, P Lionetti and A Vierucci (1997) Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? Vaccine 15 1338-1340.
129. LM Huang, BL Chiang, CY Lee, PI Lee, WK Chi and MH Chang (1999) Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 29 954-959.
130. L Ding, M Zhang, Y Wang, S Zhou, W Kong and RA Smego Jr (1993) A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect Dis 17 475-479.
131. CE Stevens, PT Toy, PE Taylor, T Lee and HY Yip (1992) Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 90 170-173.
132. SS Liao, RC Li, H Li, et al. (1999) Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 17 2661-2666.
133. P Coursaget, D Leboulleux, M Soumare, et al. (1994) Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 21 250-254.
134. Z Mintai, L Kezhou, D Lieming and RA Smego Jr (1993) Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents. Clin Infect Dis 16 165-167.
135. DY But, CL Lai, WL Lim, J Fung, DK Wong and MF Yuen (2008) Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine 26 6587-6591.
136. MA van der Sande, PA Waight, M Mendy, et al. (2007) Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One 2 e753.
137. AR Zanetti, A Mariano, L Romano, et al. (2005) Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 1379-1384.
138. F Alfaleh, S Alshehri, S Alansari, et al. (2008) Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect 57 404-409.
139. CM Dentinger, BJ McMahon, JC Butler, et al. (2005) Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 24 786-792.
140. BJ McMahon, CM Dentinger, D Bruden, et al. (2009) Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 200 1390-1396.
141. Moran JS, Peterman TA, Weinstock HS, et al. Hepatitis B vaccination trials in sexually transmitted disease clinics: implications for program development. Paper presented at: 26th National Immunization Conference; 1–6 June, 1992; St. Louis, Missouri.
142. RB Savage, MJ Hussey and MB Hurie (2000) A successful approach to immunizing men who have sex with men against hepatitis B. Public Health Nurs 17 202-206.
143. GL Armstrong, A Wasley, EP Simard, GM McQuillan, WL Kuhnert and MJ Alter (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144 705-714.
144. WR Kim (2002) The burden of hepatitis C in the United States. Hepatology 36(5 Suppl. 1), S30-S34.
145. PR Spradling, JT Richardson, K Buchacz, et al. (Sep 4 2009) Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007. J Acquir Immune Defic Syndr
146. MJ Alter (1994) Occupational exposure to hepatitis C virus: a dilemma. Infect Control Hosp Epidemiol 15 742-744.
147. BP Lanphear, CC Linnemann Jr, CG Cannon, MM DeRonde, L Pendy and LM Kerley (1994) Hepatitis C virus infection in healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 15 745-750.
148. V Puro, N Petrosillo and G Ippolito (1995) Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 23 273-277.
149. T Mitsui, K Iwano, K Masuko, et al. (1992) Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16 1109-1114.
150. RS Garfein, MC Doherty, ER Monterroso, DL Thomas, KE Nelson and D Vlahov (1998) Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 18(Suppl. 1), S11-S19.
151. MJ Alter, SC Hadler, FN Judson, et al. (1990) Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264 2231-2235.
152. MJ Alter (Nov 1997) The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1(3), 559-568. vi–vii
153. MJ Alter (1997) Epidemiology of hepatitis C. Hepatology 26(Suppl. 1), 62S-65S.
154. R Heimer, K Khoshnood, B Jariwala-Freeman, B Duncan and Y Harima (1996) Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. J Infect Dis 173 997-1000.
155. RS Garfein, D Vlahov, N Galai, MC Doherty and KE Nelson (1996) Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 86 655-661.
156. H Hagan, H Thiede, NS Weiss, SG Hopkins, JS Duchin and ER Alexander (2001) Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 91 42-46.
157. H Hagan, ER Pouget, DC Des Jarlais and C Lelutiu-Weinberger (2008) Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol 168 1099-1109.
158. R Scheinmann, H Hagan, C Lelutiu-Weinberger, et al. (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89 1-12.
159. BA Koblin, SH Factor, Y Wu and D Vlahov (2003) Hepatitis C virus infection among noninjecting drug users in New York City. J Med Virol 70 387-390.
160. RD Burt, H Hagan, RS Garfein, K Sabin, C Weinbaum and H Thiede (2007) Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18–30 years, 1994–2004. J Urban Health 84 436-454.
161. MJ Alter, RJ Gerety, LA Smallwood, et al. (1982) Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis 145 886-893.
162. C Conry-Cantilena, M VanRaden, J Gibble, et al. (1996) Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334 1691-1696.
163. JE Everhart, AM Di Bisceglie, LM Murray, et al. (1990) Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 112 544-545.
164. SC Gordon, AH Patel, GW Kulesza, RE Barnes and AL Silverman (1992) Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 87 1849-1851.
165. ME Eyster, HJ Alter, LM Aledort, S Quan, A Hatzakis and JJ Goedert (1991) Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 115 764-768.
166. C Vandelli, F Renzo, L Romano, et al. (2004) Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 99 855-859.
167. MA Balogun, ME Ramsay, JV Parry, et al. (2003) A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect 79 301-306.
168. B Marincovich, J Castilla, J del Romero, et al. (2003) Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect 79 160-162.
169. NA Terrault (2002) Sexual activity as a risk factor for hepatitis C. Hepatology 36(Suppl. 1), S99-S105.
170. DB Brettler, PM Mancci, A Gringari, et al. (1992) The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males; an international, multicenter study. Blood 80 540-543.
171. HS Weinstock, G Bolan, AL Reingold and LB Polish (1993) Hepatitis C virus infection among patients atteending a clinic for sexually transmitted diseases. JAMA 269 392-394.
172. DH Osmond, E Charlebois, HW Sheppard, et al. (1993) Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 167 66-71.
173. HM Gotz, G van Doornum, HG Niesters, JG den Hollander, HB Thio and O de Zwart (2005) A cluster of acute hepatitis C virus infection among men who have sex with men–results from contact tracing and public health implications. Aids 19 969-974.
174. DS Fierer, AJ Uriel, DC Carriero, et al. (2008) Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 198 683-686.
175. A Luetkemeyer, CB Hare, J Stansell, et al. (2006) Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 41 31-36.
176. GV Matthews, M Hellard, J Kaldor, A Lloyd and GJ Dore (2007) Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al. AIDS 21 2112-2113.
177. T van de Laar, O Pybus, S Bruisten, et al. (2009) Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136 1609-1617.
178. AT Urbanus, TJ van de Laar, IG Stolte, et al. (2009) Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. Aids 23 F1-F7.
179. M Danta, D Brown, S Bhagani, et al. (2007) Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21 983-991.
180. N Macdonald, S Dougan, CA McGarrigle, et al. (2004) Recent trends in diagnoses of HIV and other sexually transmitted infections in England and Wales among men who have sex with men. Sex Transm Infect 80 492-497.
181. RF Nieuwenhuis, JM Ossewaarde, HM Gotz, et al. (2004) Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 39 996-1003.
182. M Ruf, S Cohuet, H Maguire, et al. (2008) Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. Euro Surveill 13(47), 19042. pii
183. MO Granovsky, HL Minkoff, BH Tess, et al. (1998) Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 102 355-359.
184. S Paccagnini, N Principi, E Massironi, et al. (1995) Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 14 195-199.
185. AR Zanetti, E Tanzi, S Paccagnini, et al. (1995) Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 345 289-291.
186. JP Lam, F McOmish, SM Burns, PL Yap, JY Mok and P Simmonds (1993) Infrequent vertical transmission of hepatitis C virus. J Infect Dis 167 572-576.
187. DL Thomas, SA Villano, KA Riester, et al. (1998) Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 177 1480-1488.
188. R Novati, V Thiers, AD Monforte, et al. (1992) Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 165 720-723.
189. YH Ni, HH Lin, PJ Chen, HY Hsu, DS Chen and MH Chang (1994) Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J Hepatol 20 641-645.
190. H Ohto, S Terazawa, N Sasaki, et al. (1994) Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 330 744-750.
191. MJ Alter, PJ Coleman, WJ Alexander, et al. (1989) Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 262 1201-1205.
192. MJ Alter (1995) Epidemiology of hepatitis C in the West. Semin Liver Dis 15 5-14.
193. RL Koretz, M Brezina, AJ Polito, et al. (1993) Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 17 361-365.
194. F Marranconi, V Mecenero, GP Pellizzer, et al. (1992) HCV infection after accidental needlestick injury in health-care workers. Infection 20 111.
195. LB Seeff (1991) Hepatitis C from a needlestick injury. Ann Intern Med 115 411.
196. LB Seeff, FB Hollinger, HJ Alter, et al. (2001) Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology 33 455-463.
197. AO Shakil, C Conry-Cantilena, HJ Alter, et al. (1995) Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med 123 330-337.
198. MJ Alter, HS Margolis, K Krawczynski, et al. (1992) The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327 1899-1905.
199. LB Seeff, Z Buskell-Bales, EC Wright, et al. (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 327 1906-1911.
200. LB Seeff (1997) Natural history of hepatitis C. Hepatology 26(Suppl. 1), 21S-28S.
201. RD Aach, CE Stevens, FB Hollinger, et al. (1991) Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325 1325-1329.
202. T Poynard, P Bedossa and P Opolon (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 825-832.
203. L Roffi, A Redaelli, G Colloredo, et al. (2001) Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype. Eur J Gastroenterol Hepatol 13 501-506.
204. CS Graham, LR Baden, E Yu, et al. (2001) Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33 562-569.
205. AM Di Bisceglie, ZD Goodman, KG Ishak, JH Hoofnagle, JJ Melpolder and HJ Alter (1991) Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14 969-974.
206. K Kiyosawa, T Sodeyama, E Tanaka, et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12 671-675.
207. RS Koff and JL Dienstag (1995) Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 15 101-109.
208. MP Manns and EG Rambusch (1999) Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 31(Suppl. 1), 39-42.
209. A Pant, P Kale, K Harjai, M Shah and AV Pathare (1992) Non-A non-B hepatitis induced aplastic anemia. J Postgrad Med 38 85-86.
210. M Wise, S Bialek, L Finelli, BP Bell and F Sorvillo (2008) Changing trends in hepatitis C-related mortality in the United States, 1995–2004. Hepatology 47 1128-1135.
211. JB Wong, GM McQuillan, JG McHutchison and T Poynard (2000) Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 90 1562-1569.
212. MJ Alter, WL Kuhnert and L Finelli (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 52(RR-3), 1-13. 15; quiz CE11–14
213. SA Glynn, DJ Wright, SH Kleinman, et al. (2005) Dynamics of viremia in early hepatitis C virus infection. Transfusion 45 994-1002.
214. JD Scott and DR Gretch (2007) Molecular diagnostics of hepatitis C virus infection: a systematic review. JAMA 297 724-732.
215. Anonymous (1991) Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Recomm Rep 40(RR-4), 1-17.
216. S Kleinman, H Alter, M Busch, et al. (1992) Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 32 805-813.
217. MG Ghany, DB Strader, DL Thomas and LB Seeff (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49 1335-1374.
218. DB Strader, T Wright, DL Thomas and LB Seeff (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39 1147-1171.
219. W Vogel, I Graziadei, F Umlauft, et al. (1996) High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig Dis Sci 41(Suppl), 81S-85S.
220. J Wiegand, K Deterding, M Cornberg and H Wedemeyer (2008) Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 62 860-865.
221. E Jaeckel, M Cornberg, H Wedemeyer, et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345 1452-1457.
222. JH Hoofnagle, AS Wahed, RS Brown Jr, CD Howell and SH Belle (2009) Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. J Infect Dis 199 1112-1120.
223. CD Howell, TC Dowling, M Paul, et al. (2008) Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clin Gastroenterol Hepatol 6 575-583.
224. C Martinez-Sierra, A Arizcorreta, F Diaz, et al. (2003) Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 36 491-498.
225. N Merchante, JA Giron-Gonzalez, M Gonzalez-Serrano, et al. (2006) Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. Aids 20 49-57.
226. MG Peters and NA Terrault (2002) Alcohol use and hepatitis C. Hepatology 36(5 Suppl 1), S220-S225.
227. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 47(RR-19), 1-39. Anonymous
228. KM DeCock, B Jones, S Govindarajan and AG Redeker (1988) Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study. West J Med 148 307-309.
229. A Ponzetto, LB Seeff, Z Buskell-Bales, et al. (1984) Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology 4 1111-1115.
230. SC Hadler, M Alcala de Monzon, G Bensabath, M Martinez Duran, G Schatz and HA Fields (1991) Epidemiology of hepatitis delta virus infection in less developed countries. Prog Clin Biol Res 364 21-31.
231. YF Liaw, KW Chiu, CM Chu, IS Sheen and MJ Huang (1990) Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis 162 1170-1172.
232. L Rosenblum, W Darrow, J Witte, et al. (1992) Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 267 2477-2481.
233. SC Hadler and HA Fields (1991) Hepatitis delta virus. RB Belshe,(Eds) Textbook of Human Virology St. Louis: The C. V. Mosby Co. 749-766.
234. N Nath, IK Mushahwar, CT Fang, H Berberian and RY Dodd (1985) Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus. Am J Epidemiol 122 218-225.
235. RC Hershow, BB Chomel, DR Graham, et al. (1989) Hepatitis D virus infection in Illinois state facilities for the developmentally disabled. Epidemiology and clinical manifestations. Ann Intern Med 110 779-785.
236. RE Solomon, RA Kaslow, JP Phair, et al. (1988) Human immunodeficiency virus and hepatitis delta virus in homosexual men. A study of four cohorts. Ann Intern Med 108 51-54.
237. CL Troisi, FB Hollinger, WK Hoots, et al. (1993) A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81 412-418.
238. RH Purcell, WC Satterfield, KF Bergmann, A Smedile, A Ponzetto and JL Gerin (1987) Experimental hepatitis delta virus infection in the chimpanzee. Prog Clin Biol Res 234 27-36.
239. M Rizzetto, MG Canese, JL Gerin, WT London, DL Sly and RH Purcell (1980) Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 141 590-602.
240. S Govindarajan, KP Chin, AG Redeker and RL Peters (1984) Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86 1417-1420.
241. K Krogsgaard, LR Mathiesen, J Aldershvile, et al. (1988) Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B. Scand J Infect Dis 20 127-133.
242. A Smedile, P Farci, G Verme, et al. (1982) Influence of delta infection on severity of hepatitis B. Lancet 2 945-947.
243. NC Tassopoulos, MG Koutelou, S Macagno, P Zorbas and M Rizzetto (1990) Diagnostic significance of IgM antibody to hepatitis delta virus in fulminant hepatitis B. J Med Virol 30 174-177.
244. F Caredda, S Antinori, T Re, C Pastecchia and M Moroni (1987) Course and prognosis of acute HDV hepatitis. Prog Clin Biol Res 234 267-276.
245. T Moestrup, BG Hansson, A Widell and E Nordenfelt (1983) Clinical aspects of delta infection. Br Med J (Clin Res Ed) 286 87-90.
246. J Rinker and JT Galambos (1981) Prospective study of hepatitis B in thirty-two inadvertently infected people. Gastroenterology 81 686-691.
247. NC Tassopoulos, GJ Papaevangelou, MH Sjogren, A Roumeliotou-Karayannis, JL Gerin and RH Purcell (1987) Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 92 1844-1850.
248. G Bensabath, SC Hadler, MC Soares, et al. (1987) Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA 258 479-483.
249. G Saracco, S Macagno, F Rosina and M Rizzetto (1988) Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med 108 380-383.
250. F Bonino, F Negro, M Baldi, et al. (1987) The natural history of chronic delta hepatitis. Prog Clin Biol Res 234 145-152.
251. M Colombo, R Cambieri, MG Rumi, G Ronchi, E Del Ninno and R De Franchis (1983) Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 85(2), 235-239.
252. KM De Cock, S Govindarajan, KP Chin and AG Redeker (1986) Delta hepatitis in the Los Angeles area: a report of 126 cases. Ann Intern Med 105 108-114.
253. AU Toukan (1993) An overview of hepatitis D virus infection in Africa and the Middle East. Prog Clin Biol Res 382 251-258.
254. SC Hadler, M Alcala de Monzon, D Rivero, M Perez, A Bracho and H Fields (1992) Epidemiology and long-term consequences of hepatitis delta virus infection in the Yucpa Indians of Venezuela. Am J Epidemiol 136 1507-1516.
255. G Fattovich, G Giustina, E Christensen, et al. (2000) Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46 420-426.
256. S Govindarajan, KM De Cock and AG Redeker (1986) Natural course of delta superinfection in chronic hepatitis B virus-infected patients: histopathologic study with multiple liver biopsies. Hepatology 6 640-644.
257. E Sagnelli, FM Felaco, P Filippini, et al. (1989) Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis. Liver 9 229-234.
258. JC Wu, SD Lee, S Govindarajan, et al. (1990) Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study. J Infect Dis 161 1116-1120.
259. JL Lozano, J Crespo, F de la Cruz, et al. (1994) Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis. Med Microbiol Immunol 183 159-167.
260. G Saracco, F Rosina, MR Brunetto, et al. (1987) Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol 5 274-281.
261. SJ Hadziyannis, A Hatzakis, C Papaioannou, C Anastassakos and E Vassiliadis (1987) Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res 234 181-202.
262. G Fattovich, G Giustina, SW Schalm, et al. (1995) Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 21 77-82.
263. MC Kew, GM Dusheiko, SJ Hadziyannis and A Patterson (1984) Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma? Br Med J (Clin Res Ed) 288 1727.
264. M Aragona, S Macagno, F Caredda, et al. (1987) Serological response to the hepatitis delta virus in hepatitis D. Lancet 1 478-480.
265. F Negro and M Rizzetto (1995) Diagnosis of hepatitis delta virus infection. J Hepatol 22(Suppl. 1), 136-139.
266. P Farci, JL Gerin, M Aragona, et al. (1986) Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. JAMA 255 1443-1446.
267. AM Di Bisceglie and F Negro (1989) Diagnosis of hepatitis delta virus infection. Hepatology 10 1014-1016.
268. M Rizzetto, JW Shih and JL Gerin (1980) The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol 125 318-324.
269. R Jardi, M Buti, M Cotrina, et al. (1995) Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 21 25-29.
270. RN Chien (2008) Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B. Hepatol Int 2 296-303.
271. JH Hoofnagle (1989) Type D (delta) hepatitis. JAMA 261 1321-1325.
272. JH Hoofnagle (1994) Therapy of acute and chronic viral hepatitis. Adv Intern Med 39 241-275.
273. F Rosina, C Pintus, C Meschievitz and M Rizzetto (1991) A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology 13 1052-1056.
274. F Rosina and R Cozzolongo (1994) Interferon in HDV infection. Antiviral Res 24 165-174.
275. HC Thomas, P Farci, R Shein, et al. (1987) Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon. Prog Clin Biol Res 234 277-290.
276. P Farci, A Mandas, A Coiana, et al. (1994) Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 330 88-94.
277. F Gunsar, US Akarca, G Ersoz, et al. (2005) Two-year interferon therapy with or without ribavirin in chronic delta hepatitis. Antivir Ther 10 721-726.
278. S Kaymakoglu, C Karaca, K Demir, et al. (2005) Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrob Agents Chemother 49 1135-1138.
279. GA Niro, A Ciancio, GB Gaeta, et al. (2006) Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44 713-720.
280. DT Lau, E Doo, Y Park, et al. (1999) Lamivudine for chronic delta hepatitis. Hepatology 30 546-549.
281. D Samuel, AL Zignego, M Reynes, et al. (1995) Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology 21 333-339.
282. S Fagiuoli, G Leandro, G Bellati, et al. (1996) Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group. Ital J Gastroenterol 28 343-350.
283. GB Gaeta, T Stroffolini, M Chiaramonte, et al. (2000) Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 32 824-827.
284. TI Huo, JC Wu, RY Lin, WY Sheng, FY Chang and SD Lee (1997) Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12 747-751.
285. WL Lim, JY Lo and SH Lee (1995) Changing prevalence of hepatitis B virus and hepatitis D virus infection among injecting drug users in Hong Kong indicating a change in high-risk behaviour. AIDS 9 1110-1112.
286. E Sagnelli, T Stroffolini, A Ascione, et al. (1997) Decrease in HDV endemicity in Italy. J Hepatol 26 20-24.
287. T Stroffolini, L Ferrigno, L Cialdea, et al. (1994) Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J Hepatol 21 1123-1126.
288. SJ Hadziyannis (1997) Decreasing prevalence of hepatitis D virus infection. J Gastroenterol Hepatol 12 745-746.
289. G Da Villa, F Peluso, L Picciotto, M Bencivenga, S Elia and MG Pelliccia (1996) Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years. Vaccine 14 1503-1505.
290. SC Hadler, PJ Coleman, P O'Malley, FN Judson and N Altman (1991) Evaluation of long-term protection by hepatitis B vaccine for seven to nine years in homosexual men. FB Hollinger, SM Lemon, HS Margolis,(Eds) Viral Hepatitis and Liver Disease Baltimore: Williams and Williams 766-768.